274 related articles for article (PubMed ID: 32819181)
1. Higher TIGIT
Jin Z; Lan T; Zhao Y; Du J; Chen J; Lai J; Xu L; Chen S; Zhong X; Wu X; Li Y
Immunol Invest; 2022 Jan; 51(1):40-50. PubMed ID: 32819181
[TBL] [Abstract][Full Text] [Related]
2. Characteristic of TIGIT and DNAM-1 Expression on Foxp3+
Jin Z; Ye W; Lan T; Zhao Y; Liu X; Chen J; Lai J; Chen S; Zhong X; Wu X
Biomed Res Int; 2020; 2020():4612952. PubMed ID: 32802845
[TBL] [Abstract][Full Text] [Related]
3. CD8
Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
[TBL] [Abstract][Full Text] [Related]
4. Higher TIGIT+ γδ T
Hou Q; Wang P; Kong X; Chen J; Yao C; Luo X; Li Y; Jin Z; Wu X
Front Immunol; 2024; 15():1321126. PubMed ID: 38711501
[TBL] [Abstract][Full Text] [Related]
5. Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma.
Brauneck F; Weimer P; Schulze Zur Wiesch J; Weisel K; Leypoldt L; Vohwinkel G; Fritzsche B; Bokemeyer C; Wellbrock J; Fiedler W
Front Med (Lausanne); 2021; 8():763773. PubMed ID: 34820398
[No Abstract] [Full Text] [Related]
6. Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT
Zeng X; Yao D; Liu L; Zhang Y; Lai J; Zhong J; Zha X; Lu Y; Jin Z; Chen S; Li Y; Xu L
Asia Pac J Clin Oncol; 2022 Aug; 18(4):456-464. PubMed ID: 34811925
[TBL] [Abstract][Full Text] [Related]
7. Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.
Li W; Deng C; Yang H; Lu X; Li S; Liu X; Chen F; Chen L; Shu X; Zhang L; Liu Q; Wang G; Peng Q
Arthritis Res Ther; 2021 Jan; 23(1):15. PubMed ID: 33413573
[TBL] [Abstract][Full Text] [Related]
8. T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients.
Kong Y; Zhu L; Schell TD; Zhang J; Claxton DF; Ehmann WC; Rybka WB; George MR; Zeng H; Zheng H
Clin Cancer Res; 2016 Jun; 22(12):3057-66. PubMed ID: 26763253
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis.
Deng C; Li W; Fei Y; Wang L; Chen Y; Zeng X; Zhang F; Li Y
Front Immunol; 2020; 11():1619. PubMed ID: 32793241
[TBL] [Abstract][Full Text] [Related]
10. Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.
Zhu L; Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Palmisiano ND; Wang M; Jia B; Bayerl M; Schell TD; Hohl RJ; Zeng H; Zheng H
J Hematol Oncol; 2017 Jun; 10(1):124. PubMed ID: 28629373
[TBL] [Abstract][Full Text] [Related]
11. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract][Full Text] [Related]
12. High
Kong X; Zheng J; Liu X; Wang W; Jiang X; Chen J; Lai J; Jin Z; Wu X
Front Immunol; 2022; 13():823352. PubMed ID: 35222403
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD226 on γδ T cells is lower in advanced chronic lymphocytic leukemia and correlates with IgA, IgG and LDH levels.
Zarobkiewicz MK; Lehman N; Kowalska W; Dąbrowska I; Bojarska-Junak A
Adv Clin Exp Med; 2024 May; ():. PubMed ID: 38819939
[TBL] [Abstract][Full Text] [Related]
14. Human CD4
Šunina M; Alnek K; Kisand K; Uibo R
Scand J Immunol; 2021 Sep; 94(3):e13089. PubMed ID: 35971920
[TBL] [Abstract][Full Text] [Related]
15. Perturbed CD8
Tauriainen J; Scharf L; Frederiksen J; Naji A; Ljunggren HG; Sönnerborg A; Lund O; Reyes-Terán G; Hecht FM; Deeks SG; Betts MR; Buggert M; Karlsson AC
Sci Rep; 2017 Jan; 7():40354. PubMed ID: 28084312
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
Front Immunol; 2018; 9():2341. PubMed ID: 30364127
[TBL] [Abstract][Full Text] [Related]
17. Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis.
Liu G; Zhang Q; Yang J; Li X; Xian L; Li W; Lin T; Cheng J; Lin Q; Xu X; Li Q; Lin Y; Zhou M; Shen E
Cancer Immunol Immunother; 2022 Feb; 71(2):277-287. PubMed ID: 34129052
[TBL] [Abstract][Full Text] [Related]
18. Altered CD226/TIGIT expressions were associated with NK phenotypes in primary antiphospholipid syndrome and affected by IL-4/JAK pathway.
Long Y; Lu KJ; Xia CS; Feng JH; Li WY; Ma YT; Sun YY; Fan CH; Li C
Clin Exp Immunol; 2024 Apr; 216(2):132-145. PubMed ID: 38386917
[TBL] [Abstract][Full Text] [Related]
19. Recovery of CD226-TIGIT
Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C
Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787
[TBL] [Abstract][Full Text] [Related]
20. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
Huang Y; Zheng H; Zhu Y; Hong Y; Zha J; Lin Z; Li Z; Wang C; Fang Z; Yu X; Liu L; Xu B
Front Immunol; 2023; 14():1139517. PubMed ID: 36960073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
